Edap Tms (NASDAQ:EDAP - Get Free Report) is expected to release its Q1 2025 earnings data before the market opens on Thursday, May 15th. Analysts expect Edap Tms to post earnings of ($0.16) per share and revenue of $16.56 million for the quarter.
Edap Tms (NASDAQ:EDAP - Get Free Report) last issued its quarterly earnings data on Thursday, March 27th. The medical equipment provider reported ($0.05) EPS for the quarter, topping analysts' consensus estimates of ($0.11) by $0.06. Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%. The firm had revenue of $22.69 million for the quarter, compared to analyst estimates of $20.83 million. On average, analysts expect Edap Tms to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Edap Tms Price Performance
Shares of EDAP stock traded up $0.01 during trading hours on Friday, reaching $2.22. 18,357 shares of the company were exchanged, compared to its average volume of 96,802. Edap Tms has a fifty-two week low of $1.26 and a fifty-two week high of $7.14. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.18 and a quick ratio of 1.46. The stock's fifty day moving average is $1.96 and its two-hundred day moving average is $2.27. The company has a market cap of $82.37 million, a price-to-earnings ratio of -3.42 and a beta of 0.13.
Wall Street Analysts Forecast Growth
A number of research analysts have commented on EDAP shares. Jefferies Financial Group reiterated a "hold" rating and issued a $2.00 price objective (down from $8.00) on shares of Edap Tms in a research report on Friday, April 4th. Piper Sandler decreased their price target on Edap Tms from $5.00 to $4.50 and set an "overweight" rating on the stock in a report on Friday, March 28th. StockNews.com assumed coverage on Edap Tms in a report on Wednesday. They set a "hold" rating for the company. Finally, HC Wainwright reaffirmed a "buy" rating and issued a $19.00 target price on shares of Edap Tms in a research note on Friday, March 28th.
Check Out Our Latest Research Report on Edap Tms
About Edap Tms
(
Get Free Report)
EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.
Featured Articles
Before you consider Edap Tms, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Edap Tms wasn't on the list.
While Edap Tms currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
